| Serial Number | 86666102 |
| Word Mark | BINA |
| Filing Date | Wednesday, June 17, 2015 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, December 30, 2022 |
| Registration Number | 4976557 |
| Registration Date | Tuesday, June 14, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 29, 2016 |
| Goods and Services | Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software |
| Translation of Words in Mark | The wording "BINA" has no meaning in a foreign language. |
| Goods and Services | Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 30, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | Thursday, October 30, 2014 |
| First Use In Commerce Date | Thursday, October 30, 2014 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 30, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, October 30, 2014 |
| First Use In Commerce Date | Thursday, October 30, 2014 |
| Party Name | Roche Molecular Systems, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Pleasanton, CA 94588 |
| Party Name | Roche Molecular Systems, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Pleasanton, CA 94588 |
| Party Name | Roche Molecular Systems, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pleasanton, CA 94588 |
| Event Date | Event Description |
| Friday, December 30, 2022 | CANCELLED SEC. 8 (6-YR) |
| Monday, June 14, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Monday, October 19, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, October 19, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 19, 2020 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Monday, October 19, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 19, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 19, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, November 27, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 27, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 2, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 2, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 9, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 9, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 14, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 29, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 9, 2016 | NOTICE OF PUBLICATION |
| Monday, February 22, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Saturday, February 13, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 25, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 25, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 22, 2016 | ASSIGNED TO LIE |
| Monday, January 11, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 3, 2015 | NON-FINAL ACTION MAILED |
| Wednesday, September 2, 2015 | NON-FINAL ACTION WRITTEN |
| Monday, August 31, 2015 | ASSIGNED TO EXAMINER |
| Tuesday, June 23, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, June 20, 2015 | NEW APPLICATION ENTERED |